The use of a SOX10 reporter toward ameliorating oligodendrocyte lineage differentiation from human induced pluripotent stem cells
Glia · 2024-06 · 72 (6) · 1165-1182
DOI: 10.1002/glia.24524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 18.03.2024. Verfasst von Valerio E C Piscopo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canada First Research Excellence Fund, Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Oligodendrocytes (OLs) are key players in the central nervous system, critical for the formation and maintenance of the myelin sheaths insulating axons, ensuring efficient neuronal communication. In the last decade, the use of human induced pluripotent stem cells (iPSCs) has become essential for recapitulating and understanding the differentiation and role of OLs in vitro. Current methods include overexpression of transcription factors for rapid OL generation, neglecting the complexity of OL lineage development. Alternatively, growth factor‐based protocols offer physiological relevance but struggle with efficiency and cell heterogeneity. To address these issues, we created a novel SOX10‐P2A‐mOrange iPSC reporter line to track and purify oligodendrocyte precursor cells. Using this reporter cell line, we analyzed an existing differentiation protocol and shed light on the origin of glial cell heterogeneity. Additionally, we have modified the differentiation protocol, toward enhancing reproducibility, efficiency, and terminal maturity. Our approach not only advances OL biology but also holds promise to accelerate research and translational work with iPSC‐derived OLs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Early Drug Discovery Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada.
- Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
- Child Health and Human Development Program, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
- Neuroimmunology Unit, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada.
- Department of Pediatrics and Human Genetics, McGill University, Montreal, Quebec, Canada.
- Division of Medical Genetics, Department of Internal Medicine, McGill University Health Center, Montreal, Quebec, Canada.
ORCID-Profile: Valerio E C Piscopo, Alexandra Chapleau, Gabriela J Blaszczyk, Julien Sirois, Vincent Soubannier, Carol X-Q Chen, Geneviève Bernard, Jack P Antel, Thomas M Durcan
Förderung
- CIHR
- Canada First Research Excellence Fund
- Fonds de Recherche du Québec - Santé
- Canadian Institutes of Health Research
- Fondation du Grand défi Pierre Lavoie
Zitieren
APA
Piscopo, V. E. C., Chapleau, A., Blaszczyk, G. J., Sirois, J., You, Z., Soubannier, V., Chen, C. X., Bernard, G., Antel, J. P., & Durcan, T. M. (2024). The use of a SOX10 reporter toward ameliorating oligodendrocyte lineage differentiation from human induced pluripotent stem cells. Glia, 72(6), 1165-1182. https://doi.org/10.1002/glia.24524
Vancouver
Piscopo VEC, Chapleau A, Blaszczyk GJ, Sirois J, You Z, Soubannier V, et al. The use of a SOX10 reporter toward ameliorating oligodendrocyte lineage differentiation from human induced pluripotent stem cells. Glia. 2024;72(6):1165-1182. doi:10.1002/glia.24524
BibTeX
@article{Piscopo2024,
author = {Piscopo, Valerio E C and Chapleau, Alexandra and Blaszczyk, Gabriela J and Sirois, Julien and You, Zhipeng and Soubannier, Vincent and Chen, Carol X-Q and Bernard, Geneviève and Antel, Jack P and Durcan, Thomas M},
title = {The use of a SOX10 reporter toward ameliorating oligodendrocyte lineage differentiation from human induced pluripotent stem cells},
journal = {Glia},
year = {2024},
volume = {72},
number = {6},
pages = {1165--1182},
doi = {10.1002/glia.24524}
}
EUVIMED